Group One Trading
FBRX

Group One Trading’s Forte Biosciences FBRX Stock Holding History

Group One Trading’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$1.5K – 8428
2025
Q3 		$1.5K Buy
+100
New +$1.15K ﹤0.01% 7979
2024
Q1 		– Sell
-224
Closed -$4.6K – 7290
2023
Q4 		$4.6K Sell
224
-4,500
-95% -$62.9K ﹤0.01% 6546
2023
Q3 		$78.2K Sell
4,724
-116
-2% -$2.57K ﹤0.01% 4685
2023
Q2 		$126K Buy
4,840
+4,820
+24,100% +$125K ﹤0.01% 4389
2023
Q1 		$505 Sell
20
-92
-82% -$2.31K ﹤0.01% 6907
2022
Q4 		$2.8K Sell
112
-740
-87% -$19K ﹤0.01% 6539
2022
Q3 		$23K Hold
852
– – ﹤0.01% 5967
2022
Q2 		$28K Buy
852
+420
+97% +$13.3K ﹤0.01% 6030
2022
Q1 		$16K Sell
432
-660
-60% -$25K ﹤0.01% 6903
2021
Q4 		$58K Sell
1,092
-2,400
-69% -$161K ﹤0.01% 6204
2021
Q3 		$258K Buy
+3,492
New +$1.93M ﹤0.01% 4910
2020
Q3 		– Sell
-668
Closed -$243K – 6217
2020
Q2 		$243K Buy
668
+623
+1,384% +$278K ﹤0.01% 3219
2020
Q1 		$21K Buy
45
+41
+1,025% +$16K ﹤0.01% 4199
2019
Q4 		$1K Sell
4
-8
-67% -$1.81K ﹤0.01% 4970
2019
Q3 		$3K Sell
12
-4
-25% -$6.07K ﹤0.01% 4852
2019
Q2 		$39K Sell
16
-31
-66% -$91.9K ﹤0.01% 3899
2019
Q1 		$192K Buy
+47
New +$182K ﹤0.01% 2737
2018
Q4 		– Sell
-31
Closed -$181K – 5012
2018
Q3 		$181K Buy
31
+28
+933% +$107K ﹤0.01% 3077
2018
Q2 		$10K Sell
3
-33
-92% -$121K ﹤0.01% 4616
2018
Q1 		$160K Buy
+36
New +$167K ﹤0.01% 2939

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Group One Trading's FBRX Position: Q2 2026 in Review

Group One Trading reduced its Forte Biosciences (FBRX) stake by 49% in Q2 2026, selling an estimated $2.37K and leaving 104 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #7017.

Group One Trading first reported a position in FBRX in Q4 2018 and has held it in 27 quarters since. The position peaked at $112K in Q3 2021. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Group One Trading held 104 shares of Forte Biosciences worth $2.21K as of Q2 2026.
  • Group One Trading sold 100 Forte Biosciences shares in Q2 2026, an estimated $2.37K.
  • Forte Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7017 holding.
  • Group One Trading first reported a position in Forte Biosciences in Q4 2018 and has held it in 27 quarters since.
  • Group One Trading's Forte Biosciences position peaked at $112K in Q3 2021.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.